Concurrently, Fitch placed Centegra’s $134.7 million series 2014A and $190 million series 2012 on rating watch negative.
The rating watch negative placement reflects Fitch’s expectation that the rating will be downgraded if Centegra is not acquired by NMH as planned. The two parties are expected to sign a definitive agreement in May.
On its own, Centegra’s weak operating profitability and significantly pressured leverage metrics would suggest a multi-notch downgrade.
More articles on healthcare finance:
Allegheny Health Network posts slim profit in Q1: 5 things to know
Consumerism and the patient payment transition: 2 experts discuss
Mississippi hospital changes ER pricing policy after newspaper’s probe into child’s expensive visit
